# Avalide

NDC: 0024-5855
Generic name: irbesartan and hydrochlorothiazide
Labeler / Manufacturer: Sanofi-Aventis U.S. LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20130101

FDA application: NDA020758

## Active ingredients

- HYDROCHLOROTHIAZIDE: 12.5 mg/1
- IRBESARTAN: 150 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0024-5855"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0024-5855
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0d91895e-c869-4b33-9b83-d55c1ad6317e